Document:

DIRECTOR
AGREEMENT

    

    This DIRECTOR AGREEMENT is made as of
this _15_ day of August, 2009 (the "Agreement"), by and between China Advanced
Construction Materials Group, Inc., a Delaware corporation (the "Company") and
Larry Goldman (the “Director”).

    

    WHEREAS, the Company wishes to appoint
the Director as a non-executive member of the Board of Directors of the Company
and enter into an agreement with the Director with respect to such appointment;
and

    

    WHEREAS, the Director wishes to accept
such appointment and to serve the Company on the terms set forth herein, and in
accordance with, the provisions of this Agreement.

    

    NOW, THEREFORE, in consideration of the
mutual covenants contained herein, the parties hereto agree as
follows:

    

    1.           Position.  Subject
to the terms and provisions of this Agreement, the Company shall cause the
Director to be appointed as non-executive member of the Board of Directors (the
“Board”) to fill an existing but now vacant directorship and the Director hereby
agrees to serve the Company in that position upon the terms and conditions
hereinafter set forth, provided, however, that the Director's continued service
on the Board after the initial term on the Board shall be subject to any
necessary approval by the Company's stockholders. This Agreement is subject to
the satisfactory completion of a third party background check within sixty (60)
days of the date hereof.

    

    2.           Duties.  During
the Directorship Term (as defined in Section 5 hereof), the Director shall serve
as a member of the Board, and the Director shall make reasonable business
efforts to attend all Board meetings, serve on appropriate subcommittees as
reasonably requested by the Board, make himself available to the Company at
mutually convenient times and places, attend external meetings and
presentations, as appropriate and convenient, and perform such duties, services
and responsibilities and have the authority commensurate to such
position..

    

    The Director will use his best efforts
to promote the interests of the Company. The Company recognizes that the
Director (i) is a full-time executive employee of another entity and that his
responsibilities to such entity must have priority and (ii) sits on the Board of
Directors of other entities.  Notwithstanding same, the Director will
use reasonable business efforts to coordinate his respective commitments so as
to fulfill his obligations to the Company and, in any event, will fulfill his
legal obligations as a director. Other than as set forth above, the Director
will not, without the prior written approval of the Board, engage in any other
business activity which could materially interfere with the performance of his
duties, services and responsibilities hereunder or which is in violation of the
reasonable policies established from time to time by the Company, provided that
the foregoing shall in no way limit his activities on behalf of (i) his current
employer and its affiliates or (ii) the Board of Directors of those entities on
which he sits.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    3.            Board
Committees.      The Director hereby agrees
to Chair the Audit Committee of the Board and to perform all of the duties,
services and responsibilities necessary thereunder.

    

    4.           Monetary
Remuneration.

    

    (a)  Fees and
Compensation.  During the Directorship Term the Director shall receive
the following compensation and benefits:

    

    
      	
               
      

            	
              —

            	
              A
      monthly fee of U.S $2,083.33

            

    

    

    The Director's status during the
Directorship Term shall be that of an independent contractor and not, for any
purpose, that of an employee or agent with authority to bind the Company in any
respect. All payments and other consideration made or provided to the Director
under Sections 3 and 4 shall be made or provided without withholding or
deduction of any kind, and the Director shall assume sole responsibility for
discharging, all tax or other obligations associated therewith.

    

    (b) Restricted Stock
Award.  During the Directorship Term, the Company shall grant a
Restricted Stock in the amount of 10,000 shares of the Company’s restricted
common stock (the “Restricted Stock”). The Restricted Stock shall vest according
to the following schedule:

    

    
      	
               
      

            	
              ·

            	
              2,500
      shares of the Company’s common stock shall vest three (3) months from the
      date hereof (the “Three Month Vesting Date”) provided that the Director
      maintains a position on the Board as of the Three Month Vesting
      Date;

            

    

    

    
      	
               
      

            	
              ·

            	
              an
      additional 2,500 shares of the Company’s common stock shall vest six (6)
      months from the date hereof (the “Six Month Vesting Date”) provided that
      the Director maintains a position on the Board as of the Six Month Vesting
      Date;

            

    

    

    
      	
               
      

            	
              ·

            	
              an
      additional 2,500 shares of the Company’s common stock shall vest nine (9)
      months from the date hereof (the “Nine Month Vesting Date”) provided that
      the Director maintains a position on the Board as of the Nine Month
      Vesting Date;

            

    

    

    
      	
               
      

            	
              ·

            	
              an
      additional 2,500 shares of the Company’s common stock shall vest twelve
      (12) months from the date hereof (the “Twelve Month Vesting Date”)
      provided that the Director maintains a position on the Board as of the
      Twelve Month Vesting Date;

            

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    (c) Expense
Reimbursements.  During the Directorship Term, the Company shall
reimburse the Director for all reasonable out-of-pocket expenses incurred by the
Director in attending any in-person meetings, provided that the Director
complies with the generally applicable policies, practices and procedures of the
Company for submission of expense reports, receipts or similar documentation of
such expenses. However, all reimbursements must be approved in advance by the
Company.

    

    5.           Directorship
Term.  The "Directorship Term", as used in this Agreement,
shall mean the period commencing on the date hereof and terminating on the
earliest of the following to occur:

    

    
      
        	
              	
                (a) 
      

              	
                one
      (1) year from the date hereof, subject to a one (1) year renewal term upon
      re-election by a majority of the shareholders of the
    Company;

              

      

    

    

    (b) the
death of the Director ("Death");

    

    (c) the termination of the Director
from the position of member of the Board by the mutual agreement of the Company
and the Director;

    

    (d) the removal of the Director from
the Board by the shareholders of the Company;

    

    (e) the resignation by the Director
from the Board if after the date hereof, the Chief Executive Officer of his
current employer determines that the Director's continued service on the Board
conflicts with his fiduciary obligations to his current employer (a "Fiduciary
Resignation"); and

    

    (f) the resignation by the Director
from the Board if the board of directors or the Chief Executive Officer of his
current employer requires the Director to resign and such resignation is not a
Fiduciary Resignation.

    

    6.           Director's Representation
and Acknowledgment.  The Director represents to the Company
that his execution and performance of this Agreement shall not be in violation
of any agreement or obligation (whether or not written) that he may have with or
to any person or entity, including without limitation, any prior employer. The
Director hereby acknowledges and agrees that this Agreement (and any other
agreement or obligation referred to herein) shall be an obligation solely of the
Company, and the Director shall have no recourse whatsoever against any
stockholder of the Company or any of their respective affiliates with regard to
this Agreement.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    7.  Director
Covenants.

    

    (a)  Unauthorized
Disclosure.  The Director agrees and understands that in the
Director's position with the Company, the Director has been and will be exposed
to and receive information relating to the confidential affairs of the Company,
including but not limited to technical information, business and marketing
plans, strategies, customer information, other information concerning the
Company's products, promotions, development, financing, expansion plans,
business policies and practices, and other forms of information considered by
the Company to be confidential and in the nature of trade secrets. The Director
agrees that during the Directorship Term and thereafter, the Director will keep
such information confidential and will not disclose such information, either
directly or indirectly, to any third person or entity without the prior written
consent of the Company; provided, however, that (i) the Director shall have no
such obligation to the extent such information is or becomes publicly known or
generally known in the Company's industry other than as a result of the
Director's breach of his obligations hereunder and (ii) the Director may, after
giving prior notice to the Company to the extent practicable under the
circumstances, disclose such information to the extent required by applicable
laws or governmental regulations or judicial or regulatory process. This
confidentiality covenant has no temporal, geographical or territorial
restriction. Upon termination of the Directorship Term, the Director will
promptly return to the Company all property, keys, notes, memoranda, writings,
lists, files, reports, customer lists, correspondence, tapes, disks, cards,
surveys, maps, logs, machines, technical data or any other tangible product or
document which has been produced by, received by or otherwise submitted to the
Director in the course or otherwise as a result of the Director's position with
the Company during or prior to the Directorship Term, provided that, the Company
shall retain such materials and make them available to the Director if requested
by him in connection with any litigation against the Director under
circumstances in which (i) the Director demonstrates to the reasonable
satisfaction of the Company that the materials are necessary to his defense in
the litigation, and (ii) the confidentiality of the materials is preserved to
the reasonable satisfaction of the Company.

    

    (b)  Non-Solicitation.  During
the Directorship Term and for a period of three (3) years thereafter, the
Director shall not interfere with the Company's relationship with, or endeavor
to entice away from the Company, any person who, on the date of the termination
of the Directorship Term, was an employee or customer of the Company or
otherwise had a material business relationship with the Company.

    

    (c)  Remedies.  The
Director agrees that any breach of the terms of this Section 7 would result in
irreparable injury and damage to the Company for which the Company would have no
adequate remedy at law; the Director therefore also agrees that in the event of
said breach or any threat of breach, the Company shall be entitled to an
immediate injunction and restraining order to prevent such breach and/or
threatened breach and/or continued breach by the Director and/or any and all
entities acting for and/or with the Director, without having to prove damages,
in addition to any other remedies to which the Company may be entitled at law or
in equity. The terms of this paragraph shall not prevent the Company from
pursuing any other available remedies for any breach or threatened breach
hereof, including but not limited to the recovery of damages from the Director.
The Director acknowledges that the Company would not have entered into this
Agreement had the Director not agreed to the provisions of this Section
7.

    

    The provisions of this Section 7 shall
survive any termination of the Directorship Term, and the existence of any claim
or cause of action by the Director against the Company, whether predicated on
this Agreement or otherwise, shall not constitute a defense to the enforcement
by the Company of the covenants and agreements of this Section
7.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    8.           Indemnification.  The
Company agrees to indemnify the Director for his activities as a director of the
Company to the fullest extent permitted by law, and to cover the Director under
any directors and officers liability insurance obtained by the
Company.  Further, the Company and the Director agree to enter into an
indemnification agreement substantially in the form of agreement entered into by
the Company and its other Board members.

    

    9.           Non-Waiver of
Rights.  The failure to enforce at any time the provisions of
this Agreement or to require at any time performance by the other party of any
of the provisions hereof shall in no way be construed to be a waiver of such
provisions or to affect either the validity of this Agreement or any part
hereof, or the right of either party to enforce each and every provision in
accordance with its terms. No waiver by either party hereto of any breach by the
other party hereto of any provision of this Agreement to be performed by such
other party shall be deemed a waiver of similar or dissimilar provisions at that
time or at any prior or subsequent time.

    

    10.         Notices.  Every
notice relating to this Agreement shall be in writing and shall be given by
personal delivery or by registered or certified mail, postage prepaid, return
receipt requested; to:

    

    
      
        
          
            	
                    If
      to the Company:

                  
	 
      
	
                    China
      Advanced Construction Materials Group, Inc.

                  
	
                    Yingu
      Plaza, 9 Beisihuanxi Road, Suite 1708

                  
	
                    Haidian
      District, Beijing 100080 PRC

                  
	 
      
	
                    with
      a copy to:

                  
	 
      
	
                    Brian
      Buck

                  
	
                    Pillsbury
      Winthrop Shaw Pittman LLP

                  
	
                    2300
      N Street, N.W. Washington, DC 20037-1122

                  
	
                    Tel:
      202.663.8347 | Fax: 202.663.8007

                  
	
                    If
      to the Director:

                  
	 
      
	
                    Larry
      Goldman

                  

          

        

      

    

     

    Either of the parties hereto may change
their address for purposes of notice hereunder by giving notice in writing to
such other party pursuant to this Section 10.

    

    11.         Binding
Effect/Assignment.  This Agreement shall inure to the benefit
of and be binding upon the parties hereto and their respective heirs, executors,
personal representatives, estates, successors (including, without limitation, by
way of merger) and assigns. Notwithstanding the provisions of the immediately
preceding sentence, neither the Director nor the Company shall assign all or any
portion of this Agreement without the prior written consent of the other
party.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    12.         Entire
Agreement.  This Agreement (together with the other agreements
referred to herein) sets forth the entire understanding of the parties hereto
with respect to the subject matter hereof and supersedes all prior agreements,
written or oral, between them as to such subject matter.

    

    13.         Severability.  If
any provision of this Agreement, or any application thereof to any
circumstances, is invalid, in whole or in part, such provision or application
shall to that extent be severable and shall not affect other provisions or
applications of this Agreement.

    

    14.         Governing
Law.  This Agreement shall be governed by and construed in
accordance with the internal laws of the State of Delaware, without reference to
the principles of conflict of laws. All actions and proceedings arising out of
or relating to this Agreement shall be heard and determined in any Delaware
state or federal court and the parties hereto hereby consent to the jurisdiction
of such courts in any such action or proceeding; provided, however, that neither
party shall commence any such action or proceeding unless prior thereto the
parties have in good faith attempted to resolve the claim, dispute or cause of
action which is the subject of such action or proceeding through mediation by an
independent third party.

    

    15.           Legal
Fees.  The parties hereto agree that the non-prevailing party
in any dispute, claim, action or proceeding between the parties hereto arising
out of or relating to the terms and conditions of this Agreement or any
provision thereof (a "Dispute"), shall reimburse the prevailing party for
reasonable attorney's fees and expenses incurred by the prevailing party in
connection with such Dispute; provided, however, that the Director shall only be
required to reimburse the Company for its fees and expenses incurred in
connection with a Dispute, if the Director's position in such Dispute was found
by the court, arbitrator or other person or entity presiding over such Dispute
to be frivolous or advanced not in good faith.

    

    16.         Modifications.  Neither
this Agreement nor any provision hereof may be modified, altered, amended or
waived except by an instrument in writing duly signed by the party to be
charged.

    

    17.         Tense and
Headings.  Whenever any words used herein are in the singular
form, they shall be construed as though they were also used in the plural form
in all cases where they would so apply. The headings contained herein are solely
for the purposes of reference, are not part of this Agreement and shall not in
any way affect the meaning or interpretation of this Agreement.

    

    18.         Counterparts.  This
Agreement may be executed in two or more counterparts, each of which shall be
deemed to be an original but all of which together shall constitute one and the
same instrument.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    (remainder
of this page intentionally left blank)

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, the Company has caused this Director Agreement to be executed
by authority of its Board of Directors, and the Director has hereunto set his
hand, on the day and year first above written.

    

    CHINA
ADVANCED CONSTRUCTION MATERIALS GROUP, INC.

    

    
      
        
          	
                  By:

                	 
      
	
                  Name:
      Xianfu Han

                
	
                  Title: 
       Chief Executive
Officer

                

        

      

    

    

    DIRECTOR

    

    
      
        
          	 
      
	
                  Name:
      Larry GoldmanExhibit
10.1

     

    STOCK PURCHASE
AGREEMENT

     

    STOCK
PURCHASE AGREEMENT (this “Agreement”), made as of the date set forth below
between MYSTARU.COM,  INC., a Delaware corporation (the “Company”),
and WUKUANG IE LIMITED,
a B.V.I. corporation (the “Buyer”).

    

     

    WITNESSETH:

     

    WHEREAS,
subject to the terms and conditions herein, the Company has agreed to offer and
sell to the Buyer in a private placement, 50,000,000 shares (the “Shares”) of
the Company’s common stock, $.001 par value per share (the “Common Stock”), for
an aggregate purchase price of Three Million Dollars ($3,000,000) (the “Purchase
Price”); and

     

    WHEREAS,
the Buyer desires to purchase the Shares from the Company, and the Company
desires to sell the Shares to the Buyer, on the terms and conditions set forth
below.

     

    NOW, THEREFORE, in consideration of the
promises, mutual representations and warranties hereinafter set forth, the
parties hereto intending to be legally bound hereby, do agree as
follows:

    

    I.           PURCHASE
AND SALE OF SHARES

     

    1.1           Common
Stock.  Subject to the terms and conditions herein stated, the
Company hereby agrees to sell, issue and deliver to the Buyer, and the Buyer
agrees to purchase from the Company, the Shares at a price equal to $0.06 per
share of Common Stock.

     

    1.2           Closing. The closing
(the “Closing”) of the transaction contemplated hereby is taking place
simultaneously with the execution and delivery of this Agreement or such other
place, date and time as may be mutually agreed upon by the parties hereto (the
“Closing Date”).  At the Closing, the parties shall make the following
deliveries to each other:

     

    (a)           The
Buyer shall pay the Purchase Price to the Company in immediately available funds
by wire transfer or certified check to an account designated by the Company or
otherwise in accordance with its written instructions; and

     

    (b)           The
Company shall deliver to the Buyer a certificate registered in the name of the
Buyer, representing the Shares, receipt of which is acknowledged by the
Buyer.

     

    II.           REPRESENTATIONS
BY THE BUYER

     

    The Buyer
represents and warrants to the Company as follows:

     

    2.1           Execution.  The
execution, delivery and performance of this Agreement by the Buyer has been duly
approved by the Board of Directors or any body performing a similar function, of
the Buyer, and all other actions required to authorize and effect the purchase
of the Shares have been taken.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    2.2           Binding
Obligations.  This Agreement constitutes a valid and binding
obligation of the Buyer, enforceable in accordance with its terms, except as
limited by applicable bankruptcy, insolvency, reorganization, moratorium or
other laws of general application referring to or affecting enforcement of
creditors’ rights and general principles of equity.

     

    2.3           Non-Contravention.  Neither
the execution and delivery of this Agreement nor the purchase of Shares by the
Buyer shall, result in a material violation of, or constitute a material default
under its Certificate of Incorporation or By-Laws (or similar document), in the
performance or observance of any material obligations, agreements, covenants or
conditions contained in any debenture, note or other evidence of indebtedness or
in any material contract, indenture, mortgage, loan agreement, lease, joint
venture or other agreement or instrument to which the Buyer is a party or by
which its properties may be bound or in violation of any material order, rule,
regulation, writ, injunction, or decree of any domestic government, governmental
instrumentality or court.

     

    2.4           No Public Sale or
Distribution.  The Buyer is acquiring the Shares for its own
account for investment purposes only and not with a view towards, or for resale
in connection with, the public sale or distribution thereof, except pursuant to
sales registered or exempted under the Securities Act of 1933, as amended (the
“1933 Act); provided, however, that by
making the representations herein, the Buyer does not agree to hold any of the
Shares for any minimum or other specific term and reserves the right to dispose
of the Shares at any time in accordance with or pursuant to a registration
statement or an exemption under the 1933 Act.  The Buyer is acquiring
the securities hereunder in the ordinary course of its business.  The
Buyer presently does not have any agreement or understanding, directly or
indirectly, with any person to distribute any of the Shares.

     

    2.5           Accredited Investor
Status.  The Buyer is an "accredited investor" as that term is
defined in Rule 501(a) of Regulation D.

     

    2.6           Reliance on
Exemptions.  The Buyer understands that the Shares are being
offered and sold to it in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the
Company is relying in part upon the truth and accuracy of, and the Buyer's
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Buyer set forth herein in order to determine the
availability of such exemptions and the eligibility of the Buyer to acquire the
Shares.

     

    2.7           Information.  The
Buyer and its advisors, if any, have been furnished with all materials relating
to the business, finances and operations of the Company and materials relating
to the offer and sale of the Shares which have been requested by the
Buyer.  The Buyer and its advisors, if any, have been afforded the
opportunity to ask questions of the Company and its officers.  Neither
such inquiries nor any other due diligence investigations conducted by the Buyer
or its advisors, if any, or its representatives shall modify, amend or affect
the Buyer's right to rely on the Company's representations and warranties
contained herein.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    2.8           No Governmental
Review.  The Buyer understands that no United States federal or
state agency or any other government or governmental agency has passed on or
made any recommendation or endorsement of the Shares or the fairness or
suitability of the investment in the Shares nor have such authorities passed
upon or endorsed the merits of the offering of the Shares.

     

    2.9           Transfer or
Resale.  The Buyer understands that the Shares have not been
and are not being registered under the 1933 Act, or any state securities laws,
and may not be offered for sale, sold, assigned or transferred unless (i)
subsequently registered there under, (ii) the Buyer shall have delivered to the
Company an opinion of counsel, in a generally acceptable form, to the effect
that such Shares to be sold, assigned or transferred may be sold, assigned or
transferred pursuant to an exemption from such registration, or (iii) the Buyer
shall have satisfied the requirements of Rule 144(k) promulgated under the 1933
Act, as amended (or a successor rule thereto).  The Shares may be
pledged in connection with a bona fide margin account or other loan or financing
arrangement secured by the Shares and such pledge of Shares shall not be deemed
to be a transfer, sale or assignment of the Shares hereunder, and no Buyer
effecting a pledge of Shares shall be required to provide the Company with any
notice thereof or otherwise make any delivery to the Company pursuant to this
Agreement or any other agreements entered into by the parties hereto in
connection with the transaction contemplated by this agreement, including,
without limitation, this Section 2.9; provided, that in
order to make any sale, transfer or assignment of Shares, the Buyer and its
pledge makes such disposition in accordance with or pursuant to a registration
statement or an exemption under the 1933 Act.

     

    2.10           Legends.  The
Buyer consents to the placement of a legend on any certificate or other document
evidencing the Shares, stating that they have not been registered under the
Securities Act and setting forth or referring to the restrictions on
transferability and sale thereof.  The Buyer is aware that the Company
may make a stop order notation in its appropriate records with respect to the
restrictions on the transferability of such Shares.

     

    2.11           Organization.  The
Buyer is validly existing and in good standing under the laws of the
jurisdiction of its organization, and has the requisite power and authorization
to execute and deliver this Agreement and to consummate the transactions
contemplated hereby.

     

    2.12           Authorization; Validity;
Enforcement.  This Agreement has been duly and validly
authorized, executed and delivered on behalf of the Buyer and constitutes the
legal, valid and binding obligations of the Buyer enforceable against the Buyer
in accordance with its respective terms, except as limited by applicable
bankruptcy, insolvency, reorganization, moratorium or other laws of general
application referring to or affecting enforcement of creditors’ rights and
general principles of equity.

     

    2.13                      Placement
Agent.  No broker's, finder’s or placement agent fees or
commission will be payable to any Person retained by, or on behalf of, the
Buyers with respect to the transactions contemplated herein.

     

    2.14           No Other
Representations.  Except as set forth herein, no
representations (oral or written) have been made to the Buyer, or any
representative, by the Company or by any of its officers, directors, agents or
employees, nor anyone else on their behalf, concerning among others, the future
profitability of the Company, the future performance of the Common Stock or the
Buyer’s investment in the Company.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    III.           REPRESENTATIONS
BY THE COMPANY

     

    The
Company represents and warrants to the Buyer as follows:

     

    3.1           Organization.  The
Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of Delaware and has the corporate power to conduct
its current business and the business which it proposes to conduct.

     

    3.2           Execution.  The
execution, delivery and performance of this Agreement by the Company has been
duly approved by the Board of Directors of the Company and all other actions
required to authorize and effect the offer, sale and issuance of the Shares have
been taken.

     

    3.3           Binding
Obligations.  This Agreement constitutes a valid and binding
obligation of the Company, enforceable in accordance with its terms, except as
limited by applicable bankruptcy, insolvency, reorganization, moratorium or
other laws of general application referring to or affecting enforcement of
creditors’ rights and general principles of equity.

     

    3.4           Capitalization.  The
authorized capital stock of the Company consists of 300,000,000 shares of Common
Stock and 50,000,000 shares of preferred stock, $.001 par value (the “Preferred
Stock”).  As of July 25, 2009, 186,424,316 shares of the
Company’s Common Stock and no shares of the Company’s Preferred Stock were
issued and outstanding.  In addition, at that date, there were no
warrants and no options outstanding for the purchase of shares of Common
Stock.

     

    3.5           Issuance of
Shares.  The Shares are duly authorized and, upon issuance in
accordance with the terms hereof, shall be validly issued, free from all taxes,
liens and charges with respect to the issue thereof.  Assuming the
accuracy of each of the representations and warranties of the Buyer contained in
Section 2, the issuance by the Company of the securities is exempt from
registration under the 1933 Act.

     

    3.6           Non-Contravention.  Neither
the execution and delivery of this Agreement nor the issuance of the Shares by
the Company shall, result in a material violation of, or constitute a material
default under its Articles of Incorporation or By-Laws, in the performance or
observance of any material obligations, agreements, covenants or conditions
contained in any debenture, note or other evidence of indebtedness or in any
material contract, indenture, mortgage, loan agreement, lease, joint venture or
other agreement or instrument to which the Company is a party or by which its
properties may be bound or in violation of any material order, rule, regulation,
writ, injunction, or decree of any domestic government, governmental
instrumentality or court.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    IV.           MISCELLANEOUS

     

    4.1           Survival.  The
representations and warranties made in Articles II and III herein shall survive
the Closing for a period of one (1) year.

     

    4.2           Amendment.  This
Agreement shall not be changed, modified or amended except by a writing signed
by the parties to be charged, and this Agreement may not be discharged except by
performance in accordance with its terms or by a writing signed by the party to
be charged. This Agreement and the documents delivered in connection herewith
sets forth the entire agreement and understanding between the parties as to the
subject matter thereof and merges and supersedes all prior discussions,
agreements and understandings of any and every nature between them.

     

    4.3           Binding.  This
Agreement shall be binding upon and inure to the benefit of the parties hereto
and to their respective heirs, legal representatives, successors and
assigns.

     

    4.4           Governing Law;
Jurisdiction.  Notwithstanding the place where this Agreement
may be executed by any of the parties hereto, the parties expressly agree that
all the terms and provisions hereof shall be construed in accordance with and
governed by the laws of the State of New York, without giving effect to any
choice of law or conflicts of law provision.

     

    4.5           Severability.  The
holding of any provision of this Agreement to be invalid or unenforceable by a
court of competent jurisdiction shall not affect any other provision of this
Agreement, which shall remain in full force and effect.

     

    4.6           Waiver.  It
is agreed that a waiver by either party of a breach of any provision of this
Agreement shall not operate, or be construed, as a waiver of any subsequent
breach by that same party.

     

    4.7           Further
Assurances.  The parties agree to execute and deliver all such
further documents, agreements and instruments and take such other and further
action as may be necessary or appropriate to carry out the purposes and intent
of this Agreement.

     

    4.8           Notice.  Any
notice or other communication given hereunder shall be deemed sufficient if in
writing and sent by recognized overnight courier or registered or certified
mail, return receipt requested, or delivered by hand against written receipt
there for, addressed to the address set forth below (or to such other address as
the party shall have furnished in accordance with the provisions of this
Section):

     

    If to the
Company:

     

    MYSTARU.COM,
INC.

    6 North Twelfth Road Country Garden
Shunde District

    Foshan City, Guangdong China
528312

    Telephone:
(86) 10 6702 6968

    Facsimile:  (86)
10 6702 0769

    Attention:
Alan Lun, Chief Executive Officer

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    

    with a
copy (which shall not constitute notice) to:

     

    Kirkpatrick
& Lockhart Nicholson Graham LLP

    599
Lexington Avenue

    New York,
New York 10022

    Gen:
212.536.3900

    Fax:
212.536.3901

    Attn:  Robert
S. Matlin, Esq.

    

    If to the
Buyer:

     

    Room
1013, 10/F.,Kwong Sang Hong

    151 Hoi Bun Road Kowloon, Hong Kong

    Telephone:
852 6705 8311

    Facsimile:
852 6705 8311

    Attention:
Yvonne B. Chen c/o Wukuang IE Ltd.

    

    

    Notices
shall be deemed to have been given on the date of mailing, except for notices of
change of address, which shall be deemed to have been given when
received.

     

    4.9           Counterparts.  This
Agreement may be executed in one or more counterparts, including by facsimile,
each of which shall be deemed an original, but all of which shall together
constitute one and the same instrument.

    

    

    Remainder
of Page Intentionally Left Blank

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    IN
WITNESS WHEREOF, the parties have executed this Agreement as of the day and year
set forth below.

     

    

    Dated: August 3, 2009

    
      
        
          
            
              
                
                  
                    
                      
                        	 	BUYER:
      WUKUANG IE LIMITED	 
	 	 	 	 
	
                                 

                              	
                                By:
      

                              	/s/ Yvonne
      B. Chen	 
	 	 	Name:
      Yvonne B. Chen	 
	 	 	Title:  Director	 
	 	 	 	 
	 	 	 	 
	 	MYSTARU.COM,
      INC.	 
	 	 	 	 
	 	By:	/s/
      Alan Lun	 
	 	 	Name:  Alan
      Lun	 
	 	 	Title:   Chief
      Executive Officer	 

                      

                    

                  

                

              

            

          

        

      

    

     

    
      
         

      

      
        7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]